Skip to main content

Current and Alumni Fellows

Get to know our current fellows, and learn how IOTF is helping them achieve their professional goals in oncology product research and regulatory review. A list of all alumni fellows can be found below.

Current Fellows

Learn more about the experiences and research interests of our current fellows.

Emine Guven-Maiorov, Ph.D.

The IOTF fellowship is an exceptional opportunity to have a foundation of knowledge and gain hands-on experience in intricate details of drug development process and its regulation. It is a great program for scientists who are interested in pursuing alternative science-based careers because you will still be immersed in science, getting an extensive one-on-one training from a regulatory expert, learning state-of-the-art technologies, meeting people from diverse fields, as well as contributing in part to translation of scientific inventions to commercial products and improving public health.

Dr. Guven Maiorov received her B.Sc. in Molecular Biology and Genetics at Bogazici University and her M.Sc. and Ph.D. in Chemical and Biological Engineering at the Koc University, Istanbul/Turkey.  She then performed 3.5 years of post-doctoral training in the laboratory of Dr. Ruth Nussinov in the Cancer Inflammation Program at the National Cancer Institute.  Dr. Guven Maiorov joined the IOTF Fellowship in 2019 as a product quality research/review fellow in the laboratory of Dr. Wendy Weinberg.  In Dr. Weinberg’s lab, she utilizes computational approaches to evaluate the structural determinants and interactions between p63 – a p53 homologue – and downstream effector molecules to determine the 3D structure of protein-protein interaction complexes relevant to tumorigenesis and sensitivity/resistance to cancer therapeutics. She is also analyzing biotechnology products, such as monoclonal antibodies, to link to observed adverse events for elucidation of molecular mechanism(s).  Her long-term career goal is to continue to work as a full-time reviewer at FDA and contribute to FDA’s public health mission by assuring safety, efficacy, and quality of drugs and biologics.

Dr. Guven-Maiorov's IOTF Experience

“The IOTF fellowship is an exceptional opportunity to have a foundation of knowledge and gain hands-on experience in intricate details of drug development process and its regulation. It is a great program for scientists who are interested in pursuing alternative science-based careers because you will still be immersed in science, getting an extensive one-on-one training from a regulatory expert, learning state-of-the-art technologies, meeting people from diverse fields, as well as contributing in part to translation of scientific inventions to commercial products and improving public health.”


Ancy Nalli, Ph.D.

This fellowship is an excellent program for fellows interested in the regulatory review process. It is an opportunity to perform FDA mission relevant research and get hands-on regulatory review experience. The training is instrumental in understanding the life cycle of investigational new drug applications and translating research expertise to regulatory review.

Dr. Nalli received her Ph.D. in Physiology with a concentration in Molecular Biology and Genetics at Virginia Commonwealth University in Richmond, VA. After graduation, she completed three years of post-doctoral training in the Molecular Targets Program at the National Cancer Institute.  There she studied the role of small molecule therapeutics to sensitize resistant cancer cells to Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.  Dr. Nalli joined the IOTF Fellowship in September 2018 as a product quality research/review fellow, where she studies the development of cell-based assays to evaluate the bioactivity of reference materials for the TNF-alpha blocker, adalimumab.  Her work is as part of an international collaborative study with the World Health Organization (WHO) to develop the 1st international standard (IS) for adalimumab.  Her long-term career goal is to become a product quality reviewer for biotechnology products.

Dr. Nalli's IOTF Experience

“This fellowship is an excellent program for fellows interested in the regulatory review process. It is an opportunity to perform FDA mission relevant research and get hands-on regulatory review experience. The training is instrumental in understanding the life cycle of investigational new drug applications and translating research expertise to regulatory review.”


Alumni Fellows

Here is a list of IOTF fellows, listed by cohort year.

Qiong Fu, Ph.D.

Dr. Qiong Fu received her Ph.D. in Microbiology with a focus on protein Biochemistry at The University of Austin, Texas. After graduation, Dr. Fu completed one year of post-doctoral training in the same lab at UT Austin and then joined the Thoracic and Gastrointestinal Malignancies Branch at National Cancer Institute (NCI) in 2016.  In the Greten laboratory, she studied the functions of immune cells in liver cancer progression and worked to develop new immune therapeutic proteins for liver cancer.  Dr. Fu joined the IOTF Fellowship in 2018 where she used the anthrax lethal toxin as a tool to dissect the MAPK signaling pathway, with a goal to predict new molecular targets for anti-cancer drugs.  In 2019, she joined the FDA as a Product Quality Reviewer in the Office of Biotechnology Products.

Michael Moses, Ph.D.

Dr. Michael Moses received his Ph.D. in Pathology at the University of Rochester. He then went on to perform 4 years of post-doctoral training in the laboratory of Dr. Len Neckers in the Urologic Oncology Branch at the National Cancer Institute. He joined the IOTF Fellowship in September 2018 as a product quality research/review fellow in the laboratory of Dr. Wendy Weinberg where he studied the role of the p53 homologue, p63, specifically the ΔNp63α isotype, in the regulation of metabolic networks in cutaneous and other squamous cell cancers.  In 2019, Dr. Moses joined the FDA as a CMC Reviewer in the Center for Biologics Evaluations and Research.

2017

  • Danielle Brooks, Ph.D.
  • Andrew Harmon, Ph.D.
  • Elizabeth Lessey Morillon, Ph.D.
  • Jun Zhao, Ph.D.

2016

  • Andrea George, Ph.D.
  • Karol Szczepanek, Ph.D.
  • Mayumi Takahashi, Ph.D.

2015

  • Ekaterina Allen, Ph.D.
  • Aysegul Ergen, Ph.D.
  • Anna Kwilas, Ph.D.
  • Sandhya Sanduja, Ph.D.
  • Nailing Zhang

See more IOTF Alumni from 2009-2014.

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Current and Alumni Fellows was originally published by the National Cancer Institute.”